• The experience with proved pancreatic adenocarcinoma in Portland, Ore, for 1965 through 1975 is compared with the decade 1955 through 1965. Little difference is found in time of diagnosis, incidence of resection vs bypass or laparotomy, types of resection, and overall survival. However, operative mortality improved and survival after total pancreatectomy improved from seven to 23 months. Whipple resections leave residual pancreatic tumor in one third of patients. Combining fluorouracil and radiotherapy significantly increases survival after palliative bypass (15 months vs 7.4 months, P <.02). Based on low operative mortality, improved survival, and avoidance of residual tumor, use of total pancreatectomy as the resection of choice is recommended.
(Arch Surg 113:1401-1404, 1978)
Knight RW, Scarborough JP, Goss JC. Adenocarcinoma of the Pancreas: A Ten-Year Experience. Arch Surg. 1978;113(12):1401–1404. doi:10.1001/archsurg.1978.01370240023003
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: